Page last updated: 2024-08-05 11:01:50
tryptamine alkaloid
null
ChEBI ID: 48274
Members (7)
Member | Definition | Role |
---|---|---|
baeocystin | A tryptamine alkaloid that is N-methyltryptamine carrying an additional phosphoryloxy substituent at position 4. | baeocystin |
bufotenin | A tertiary amine that consists of N,N-dimethyltryptamine bearing an additional hydroxy substituent at position 5. | bufotenin |
methylbufotenin | A tryptamine alkaloid that is N,N-dimethyltryptamine substituted by a methoxy group at position 5. | 5-methoxy-N,N-dimethyltryptamine |
n-methyltryptamine | N-methyltryptamine | |
n,n-dimethyltryptamine | A tryptamine derivative having two N-methyl substituents on the side-chain. | N,N-dimethyltryptamine |
psilocin | A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional hydroxy substituent at position 4. A hallucinogenic alkaloid isolated in trace amounts from Psilocybe mushrooms (also known as Teonanacatl or "magic mushrooms"). | psilocin |
psilocybin | A tryptamine alkaloid that is N,N-dimethyltryptamine carrying an additional phosphoryloxy substituent at position 4. The major hallucinogenic alkaloid isolated from Psilocybe mushrooms (also known as Teonanacatl or "magic mushrooms"). | psilocybin |
Research
Studies (1,642)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 656 (39.95) | 18.7374 |
1990's | 91 (5.54) | 18.2507 |
2000's | 133 (8.10) | 29.6817 |
2010's | 270 (16.44) | 24.3611 |
2020's | 492 (29.96) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 142 (7.03%) | 5.53% |
Reviews | 308 (15.24%) | 6.00% |
Case Studies | 65 (3.22%) | 4.05% |
Observational | 8 (0.40%) | 0.25% |
Other | 1,498 (74.12%) | 84.16% |